Medullary Thyroid Cancer (MTC) Completed Phase 1 Trials for Temsirolimus (DB06287)

Also known as: Thyroid Carcinoma, Medullary / Medullary carcinoma of thyroid / Thyroid Gland Medullary Carcinoma / Thyroid Medullary Carcinoma / Thyroid Cancer, Medullary / Medullary Thyroid Carcinoma / Medullary Thyroid Cancer / Medullary thyroid carcinoma (disorder) / Medullary carcinoma with amyloid stroma (morphologic abnormality) / Parafollicular cell carcinoma (disorder) / Medullary thyroid carcinoma (morphologic abnormality) / C cell neuroendocrine neoplasm / Parafollicular cell carcinoma / C cell carcinoma / Ultimobranchial thyroid tumor / Ultimobranchial thyroid tumour / MTC - Medullary thyroid carcinoma / Medullary carcinoma with amyloid stroma -RETIRED-

IndicationStatusPhase
DBCOND0062236 (Medullary Thyroid Cancer (MTC))Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01155258
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsTreatment